These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 22904633)

  • 21. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.
    Fonseca C; Simões S; Gaspar R
    J Control Release; 2002 Oct; 83(2):273-286. PubMed ID: 12363453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
    J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
    Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
    Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayer.
    Xie J; Lei C; Hu Y; Gay GK; Bin Jamali NH; Wang CH
    Curr Pharm Des; 2010 Jul; 16(21):2331-40. PubMed ID: 20618154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
    Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A
    Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.
    Qiao C; Zhang K; Jin H; Miao L; Shi C; Liu X; Yuan A; Liu J; Li D; Zheng C; Zhang G; Li X; Yang B; Sun H
    Int J Nanomedicine; 2013; 8():2985-95. PubMed ID: 23990717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
    Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
    Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
    Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
    Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
    J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier.
    d'Angelo I; Costabile G; Durantie E; Brocca P; Rondelli V; Russo A; Russo G; Miro A; Quaglia F; Petri-Fink A; Rothen-Rutishauser B; Ungaro F
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):170-181. PubMed ID: 29035132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
    Yang R; Yang SG; Shim WS; Cui F; Cheng G; Kim IW; Kim DD; Chung SJ; Shim CK
    J Pharm Sci; 2009 Mar; 98(3):970-84. PubMed ID: 18661542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
    Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
    Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent magnetic PEI-PLGA nanoparticles loaded with paclitaxel for concurrent cell imaging, enhanced apoptosis and autophagy in human brain cancer.
    Wang X; Yang L; Zhang H; Tian B; Li R; Hou X; Wei F
    Colloids Surf B Biointerfaces; 2018 Dec; 172():708-717. PubMed ID: 30245296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles.
    Pramual S; Lirdprapamongkol K; Jouan-Hureaux V; Barberi-Heyob M; Frochot C; Svasti J; Niamsiri N
    Eur J Pharm Biopharm; 2020 Apr; 149():218-228. PubMed ID: 32112893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K; Yamamoto H; Hirashima N; Kawashima Y
    Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of STAT3 expression in SKOV3 cells by biodegradable siRNA-PLGA/CSO conjugate micelles.
    Zhao Y; Zheng C; Zhang L; Chen Y; Ye Y; Zhao M
    Colloids Surf B Biointerfaces; 2015 Mar; 127():155-63. PubMed ID: 25677339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine I: In vitro and in vivo evaluation of paclitaxel loaded poly-(ε-caprolactone), poly (DL-lactide-co-glycolide) and poly (DL-lactic acid) matrix nanoparticles in wistar rats.
    VasanthaKumar S; Ahamed HN; Saha RN
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):137-61. PubMed ID: 24671895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.